Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it…
Pipeline Medical Affairs: An Orchestra, Not a Horse Race
Every horse race has a starting bell, a push to move as fast as possible, and a…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more…
Freedom to Lead
In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to…
Rare Diseases — It’s All About the Patient
Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th anniversary of the Orphan Drug…
Planning Amidst the Mayhem
Maybe you noticed – 2020 was a crazy year. Like meeting the Pope or becoming a parent for the first time, the phrase "once in a lifetime" keeps…
There Is No Such Thing as a Free Launch!
One of the things I've enjoyed about working with The NemetzGroup is the exposure to so many organizations and the amazing work they are doing for…
Making Virtual Workshops Work
Workshops, whether in the form of a half-day strategy session, a company-wide offsite or some other configuration, have one thing in common: They…
What’s Different Now
In just one month, life for all of us has changed dramatically. This week, we learned that the new normal would extend at least through April,…
